Almac Sciences Adds Biologics Testing to its Analytical Solutions Suite

Publication
Article
In the Lab eNewsletterPharmaceutical Technology's In the Lab eNewsletter 10-07-2020
Volume 15
Issue 10

With a recent expansion, Almac will now have the ability to include enhanced analytical method development and bioanalytical testing.

Almac Sciences, a member of the Almac Group, is undergoing expansion to add biologics testing to its suite of analytical solutions.

The expansion will include current good manufacturing practice (CGMP) lot release and stability testing, fit-for-purpose analytical method development, phase-appropriate method validation, and raw material testing for microbial and mammalian expression systems.

“Biologics have gained huge traction in the last decade and are poised for stronger growth in the coming years with potential to significantly impact patient lives,” said Dr. John Robson, vice-president, Analytical Operations, Almac Sciences, in a Sept. 24, 2020 company press release. “The launch of this service offering furthermore demonstrates Almac’s commitment to offering a best-in-class service to our global client base and in advancing human health. We are confident the addition of biologics testing solutions will continue to strengthen our competitive position in the marketplace.”

Source: Almac​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​

Articles in this issue
Restructuring Method Transfer Throughout Global Sites
Restructuring Method Transfer Throughout Global Sites
Darren Baker/Stock.Adobe.com - scientist observing test tube
When Assessing Protein Aggregation Grows Increasingly Challenging
Almac Sciences Adds Biologics Testing to its Analytical Solutions Suite
PharmaLex Group Completes Merger with BioStat Solutions
Natoli Installs Tablet Press at its New Research and Training Facility
Thermo Fisher to Invest More than $140 Million into its Lab Plastics Consumables for COVID-19 Testing
Sai Life Sciences’ Screening Capabilities Enhanced with Expanded Cellular Analysis Platforms
StarBright Violet 515 Dye from Bio-Rad Enhances Flow Cytometry
Paradigm4’s Single Cell App Allows for Analysis of Large-Scale Datasets
CytoSMART Technologies’ New Automated Live-Cell Imaging System Keeps Lab Teams Coordinated
Promega’s New Capillary Electrophoresis Instrument Enhances Benchtop Analysis
Aigenpulse’s Data Analysis Suite Automates Flow Cytometry
Recent Videos
US tariff rate rising , trade policy , business graph and dollars banknote , tax calculation change | Image Credit: © janews094 - stock.adobe.com
Related Content
Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept. | Image Credit: © Dilok - stock.adobe.com

Paige, Sonrai Form Partnership to Harness AI for Precision Medicine R&D

Patrick Lavery
April 21st 2025
Article
Site Logo

Transformations in Drug Development for Cell and Gene Therapies

PPD;Thermo Fisher Scientific
March 28th 2025
Podcast

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Bavarian Nordic Chikungunya Vaccine Recommended by CDC's ACIP

Patrick Lavery
April 18th 2025
Article

The recombinant vaccine, under the brand name Vimkunya, is recommended for persons age 12 and older who are traveling to a country or territory where there is a chikungunya outbreak.

Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang

Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang

PPD;Thermo Fisher Scientific
March 28th 2025
Podcast

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

New CDMO Meribel Pharma Solutions Launches with 13 Sites in Europe

Patrick Lavery
April 16th 2025
Article

The new United Kingdom-based firm has sites located in France, Spain, and Sweden, thanks to an acquisition of Synerlab Group and several Recipharm facilities in 2024.

Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact

Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact

Alicia Bigica
April 16th 2025
Article

On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.